The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes
Abstract
Information on the molecular distribution and ageing trend of brain iron in post-mortem material from normal subjects is scarce. Because it is known that neuromelanin and ferritin form stable complexes with iron(III), in this study we measured the concentration of iron, ferritin and neuromelanin in substantia nigra from normal subjects, aged between 1 and 90 years, dissected post mortem. Iron levels in substantia nigra were 20 ng/mg in the first year of life, had increased to 200 ng/mg by the fourth decade and remained stable until 90 years of age. The H-ferritin concentration was also very low (29 ng/mg) during the first year of life but increased rapidly to values of approximately 200 ng/mg at 20 years of age, which then remained constant until the eighth decade of life. L-Ferritin also showed an increasing trend during life although the concentrations were approximately 50% less than that of H-ferritin at each age point. Neuromelanin was not detectable during the first year, increased to approximately 1000 ng/mg in the second decade and then increased continuously to 3500 ng/mg in the 80th year. A Mössbauer study revealed that the high-spin trivalent iron is probably arranged in a ferritin-like iron--oxyhydroxide cluster form in the substantia nigra. Based on this data and on the low H- and L-ferritin content in neurones it is concluded that neuromelanin is the major iron storage in substantia nigra neurones in normal individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the substantia nigra, ferritin heavy chain and ferritin light chain concentrations increase with age, whereas these are constant in the locus coeruleus; therefore iron could contribute to neurodegeneration in the substantia nigra more than in the locus coeruleus.5,6”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [5]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. A., & SEITELBERGER, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,650
The effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Biochemical pathophysiology of Parkinson's disease.
Hornykiewicz, O., & Kish, S. J. (1987) · PubMed · Cited by 850
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P. F., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G. F., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 754
Aging and Extrapyramidal Function
McGeer, P. L., McGeer, E. G., & Suzuki, J. S. (1977) · Archives of Neurology · doi:10.1001/archneur.1977.00500130053010 · Cited by 648
Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains
Connor, J. R., Menzies, S. L., Martin, S. M. S., & Mufson, E. J. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270421 · Cited by 472
Inorganic Biochemistry of Iron Metabolism: From Molecular Mechanisms to Clinical Consequences
Crichton, R. (2001) · doi:10.1002/0470845791 · Cited by 453
Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases
Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., & Youdim, M. B. H. (1990) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02252926 · Cited by 445
Self-citationGood, P. F., Olanow, C. W., & Perl, D. P. (1992) · Brain Research · doi:10.1016/0006-8993(92)91334-b · Cited by 427
(1999) · PubMed · Cited by 425
Pakkenberg, B., Møller, A., Gundersen, H. J. G., Dam, A. M., & Pakkenberg, H. (1991) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.1.30 · Cited by 408
Spencer, J. P. E., Jenner, P., Daniel, S. E., Lees, A. J., Marsden, D. C., & Halliwell, B. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052112.x · Cited by 373
Mössbauer Spectroscopy and Transition Metal Chemistry
Gütlich, P., Link, R., & TRAUTWEIN, A. X. (1978) · Inorganic chemistry concepts · doi:10.1007/978-3-662-12545-8 · Cited by 347
Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions
Loeffler, D. A., Connor, J. R., Juneau, P. L., Snyder, B. S., Kanaley, L., DeMaggio, A. J., Nguyen, H., Brickman, C. M., & LeWitt, P. A. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020710.x · Cited by 334
Connor, J. R., Snyder, B. S., Arosio, P., Loeffler, D. A., & LeWitt, P. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020717.x · Cited by 317
Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis
Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben‐Shachar, D., & Youdim, M. B. H. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08362.x · Cited by 313
Selectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP + Binds to Neuromelanin
D’Amato, R. J., Lipman, Z. P., & Snyder, S. H. (1986) · Science · doi:10.1126/science.3080808 · Cited by 296
Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease
Ben‐Shachar, D., Riederer, P. F., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06358.x · Cited by 287
Intraneuronal dopamine-quinone synthesis: a review
Sulzer, D., & Zecca, L. (1999) · Neurotoxicity Research · doi:10.1007/bf03033289 · Cited by 284
Self-citationDecreased ferritin levels in brain in Parkinson's disease
Dexter, D. T., Carayon, A., Vidailhet, M., Ruberg, M., Agid, F., Agid, Y., Lees, A. J., Wells, F. R., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08814.x · Cited by 258
Iron in the basal ganglia in Parkinson's disease
Griffiths, P. D., Dobson, B. R., Jones, G. R., & Clarke, D. T. (1999) · Brain · doi:10.1093/brain/122.4.667 · Cited by 229
Kästner, A., Hirsch, É. C., Lejeune, O., Javoy-Agid, F., Rascol, O., & Agid, Y. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08350.x · Cited by 228
Developmental changes in transferrin and iron uptake by the brain in the rat
Taylor, E. M., & Morgan, E. H. (1990) · Developmental Brain Research · doi:10.1016/0165-3806(90)90103-6 · Cited by 221
LIPOPROTEIN PIGMENTS—THEIR RELATIONSHIP TO AGEING IN THE HUMAN NERVOUS SYSTEM
Mann, D. M. A., & Yates, P. O. (1974) · Brain · doi:10.1093/brain/97.1.489 · Cited by 214
Tyrosine mRNA is expressed in human substantia nigra
Xu, Y., Stokes, A. H., Freeman, W. M., Kumer, S. C., Vogt, B. A., & Vrana, K. E. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00308-7 · Cited by 205
Interaction of neuromelanin and iron in substantia nigra and other areas of human brain
Zecca, L., Shima, T., Stroppolo, A., Goj, C., Battiston, G. A., Gerbasi, R., Sarna, T., & Swartz, H. M. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00047-4 · Cited by 197
Bartzokis, G., & Tishler, T. A. (2000) · PubMed · Cited by 196
Isoforms of ferritin have a specific cellular distribution in the brain
Connor, J. R., Boeshore, K. L., Benkovic, S. A., & Menzies, S. L. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370405 · Cited by 179
TRAUTWEIN, A. X., Bill, E., Bominaar, E. L., & WINKLER, H. (1991) · Structure and bonding · doi:10.1007/3-540-54261-2_1 · Cited by 175
Iron and Other Metals in Neuromelanin, Substantia Nigra, and Putamen of Human Brain
Zecca, L., Pietra, R., Goj, C., Mecacci, C., Radice, D., & Sabbioni, E. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031097.x · Cited by 163
Preservation of midbrain catecholaminergic neurons in very old human subjects
Kubis, N., Faucheux, B. A., Ransmayr, G. N., Damier, P., Duyckaerts, C. J., Hénin, D., Forette, B., Charpentier, Y. L., Hauw, J., Agid, Y., et al. (2000) · Brain · doi:10.1093/brain/123.2.366 · Cited by 157
Mössbauer spectroscopic studies of human haemosiderin and ferritin
Bell, S. H., Weir, M., Dickson, D. P. E., Gibson, J. F., Sharp, G. A., & Peters, T. J. (1984) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(84)90313-3 · Cited by 151
Shima, T., Sarna, T., Swartz, H. M., Stroppolo, A., Gerbasi, R., & Zecca, L. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00623-5 · Cited by 135
Zhang, F., & Dryhurst, G. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00034a006 · Cited by 129
Total and paramagnetic metals in human substantia nigra and its neuromelanin
Zecca, L., & Swartz, H. M. (1993) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257675 · Cited by 123
Altered systemic iron metabolism in Parkinson's disease
Logroscino, G., Marder, K. S., Graziano, J. H., Freyer, G. A., Slavkovich, V. N., LoIacono, N. J., Cote, L. J., & Mayeux, R. P. (1997) · Neurology · doi:10.1212/wnl.49.3.714 · Cited by 118
Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: Accumulation in neuromelanin
Lindquist, N. G., Larsson, B. S., & Lydén‐Sokolowski, A. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90002-x · Cited by 114
Mössbauer Spectroscopic Studies of Purified Human Neuromelanin Isolated from the Substantia Nigra
Gerlach, M., TRAUTWEIN, A. X., Zecca, L., Youdim, M. B. H., & Riederer, P. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020923.x · Cited by 114
Inorganic biochemistry of iron metabolism
Eastham, B. (1992) · Biochemical Education · doi:10.1016/0307-4412(92)90222-8 · Cited by 109
New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain
Tief, K., Schmidt, A., & Beermann, F. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00301-x · Cited by 105
Iron in parkinsonian and control substantia nigra—A mössbauer spectroscopy study
Gałązka-Friedman, J., Bauminger, E. R., Friedman, A., Barcikowska, M., Hechel, D., & Nowik, I. (1996) · Movement Disorders · doi:10.1002/mds.870110104 · Cited by 102
The chemical characterization of melanin contained in substantia nigra of human brain
Zecca, L., Mecacci, C., Seraglia, R., & Parati, E. A. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(92)90144-c · Cited by 101
Muthane, U. B., Yasha, T. C., & Shankar, S. K. (1998) · Annals of Neurology · doi:10.1002/ana.410430304 · Cited by 97
Interaction of Human Substantia Nigra Neuromelanin with Lipids and Peptides
Zecca, L., Costi, P., Mecacci, C., Ito, S., Terreni, M., & Sonnino, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741758.x · Cited by 95
Immunochemical characterization of human liver and heart ferritins with monoclonal antibodies
Luzzago, A., Arosio, P., Iacobello, C., Ruggeri, G., Capucci, L., Brocchi, E., Simone, F., Gamba, D., Gabri, E., Levi, S., et al. (1986) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(86)90147-0 · Cited by 93
Offen, D. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00150-7 · Cited by 90
Enzyme Activity of Macrophage Migration Inhibitory Factor toward Oxidized Catecholamines
Matsunaga, J., Sinha, D., Pannell, L., Santis, C., Solano, F., Wistow, G. J., & Hearing, V. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3268 · Cited by 85
The Development of the Blood-Brain Barrier
Dobbing, J. (1968) · Progress in brain research · doi:10.1016/s0079-6123(08)64172-2 · Cited by 81
On the function of neuromelanin
Smythies, J. (1996) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1996.0073 · Cited by 76
Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra?
Ikemoto, K., Nagatsu, I., Ito, S., King, R. A., Nishimura, A., & Nagatsu, T. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00649-1 · Cited by 74
Modulation by neuromelanin of the availability and reactivity of metal ions
Swartz, H. M., Sarna, T., & Zecca, L. (1992) · Annals of Neurology · doi:10.1002/ana.410320712 · Cited by 73
Shen, X.-M., Xia, B., Wrona, M. Z., & Dryhurst, G. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960052v · Cited by 67
Q-band EPR investigations of neuromelanin in control and Parkinson’s disease patients
Lopiano, L., Chiesa, M., Digilio, G., Giraudo, S., Bergamasco, B., Torre, E., & Fasano, M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00116-7 · Cited by 50
Kropf, A. J., Bunker, B. A., Eisner, M., Moss, S. C., Zecca, L., Stroppolo, A., & Crippa, P. R. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77755-0 · Cited by 43
Transient overexpression of human H- and L-ferritin chains in COS cells
Corsi, B., Perrone, F., Bourgeois, M., Beaumont, C., Panzeri, M. C., Cozzi, A., Sangregorio, R., Santambrogio, P., Albertini, A., Arosio, P., et al. (1998) · Biochemical Journal · doi:10.1042/bj3300315 · Cited by 42
The distribution of iron in the brain: A phylogenetic analysis using iron histochemistry
Erb, G. L., Osterbur, D., & LeVine, S. M. (1996) · Developmental Brain Research · doi:10.1016/0165-3806(96)00020-x · Cited by 35
Research works printed but not linked: 2
- Moos T., 2000, Absence of ferritin protein in substantia nigra pars compacta neurons. A reappraisal to the role of iron in Parkinson disease pathogenesis, Mov. Disord., 15, 319A
- Zareba M., 1995, The effect of synthetic neuromelanin on yeld of free hydroxyl radicals generated in model system, Biochim. Biophys. Acta, 1138, 6
Cited by
Sorted by citations
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
The physical and chemical properties of eumelanin
Meredith, P., & Sarna, T. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00345.x · Cited by 1,033
Kell, D. B., & Pretorius, E. (2014) · Metallomics · doi:10.1039/c3mt00347g · Cited by 667
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
Self-citation
Metadata
- Authors
- Zecca, L., Gallorini, M., Schünemann, V., Trautwein, A. X., Gerlach, M., Riederer, P., Vezzoni, P., & Tampellini, D.
- Affiliations
- Institute of Biomedical Technologies (IT)
- University of Pavia (IT)
- University of Lübeck (DE)
- University of Würzburg (DE)
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2001-03-15
- Volume
- 76
- Issue
- 6
- Pages
- 1766-1773
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1601438958
- Cited by
- 401
- References
- 61
- Citations by year
- 2026: 7 · 2025: 16 · 2024: 11 · 2023: 13 · 2022: 19 · 2021: 25 · 2020: 13 · 2019: 20 · 2018: 23 · 2017: 18 · 2016: 19 · 2015: 10 · 2014: 14 · 2013: 17 · 2012: 14
- FWCI
- 8.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Fondazione Cariplo
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- brain iron, substantia nigra, neuromelanin, ferritin, iron storage, aging, neurodegeneration, high-spin iron, postmortem brain
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aging, Child, Child, Preschool, Ferritins, Humans, Infant, Iron, Melanins, Middle Aged, Nerve Degeneration, Reference Values, Substantia Nigra
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review